Siddarth Satish
Chief Executive Officer
Description:
Siddarth Satish is the Chief Executive Officer of Gauss Surgical. He founded the company in 2011 and served as CTO and Chairman of the Board until 2015. In his operating roles, he has led the company from invention through six US/EU regulatory approvals (including FDA De Novo), and into its commercial phase of growth. Siddarth previously served as an EIR at StartX, Stanford’s Startup Accelerator, and as a SIMdesign Fellow at the Stanford University School of Medicine. He holds a B.S. in Chemical Engineering from the University of California, Berkeley, and an M.S. in Bioengineering from the UC Berkeley/UCSF Joint Graduate Group in Bioengineering, and he is a named inventor on over 25 issued or pending patents.
Summary:
Siddarth Satish is the Chief Executive Officer of Gauss Surgical. He founded the company in 2011 and served as CTO and Chairman of the Board...
Number of Registered Investments:1
Contact Details:
- Address: San Francisco, California, United States
- No email is provided
Location:San Francisco, California, United States
Email is Not Provided
Phone Number:San Francisco, California, United States
Updated August 2023. This content was crafted by an associate of Najafi Capital (“Najafi”) and is presented strictly for informational objectives. The details on this page neither advocate for nor dissuade the subscription, acquisition, or sale of any security or offering. The material Najafi evaluates for project owner screening and due diligence stems directly from the project owner presenting the investment opportunity. While Najafi perceives the information to have been sourced from trustworthy channels, there is no absolute assurance, warranty, or representation concerning its authenticity. Najafi renounces any liability regarding content provided by the project owner, inclusive of the data utilized to fulfill elements outlined on this page. Najafi is not accountable for the precision, legality, or the affirmation of subsequent details shared by the project owner.
Prospective investors are urged to perform their individual due diligence and authenticate the provided data. Investing inherently encompasses risks, inclusive of the potential loss of capital invested. All investors are recommended to ponder over these aspects in tandem with a chosen professional consultant to ascertain the suitability of an investment.